Global Autoimmune Disease Diagnostics and Drugs Market

1. Summary

The Global Autoimmune Disease Diagnostics and Drugs Market was valued at $175 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 3.9% CAGR, to an estimated market size of $212 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The global autoimmune disease diagnostics and drugs market encompasses the development, manufacturing, and sale of therapeutic agents (including biologics, monoclonal antibodies, and immunosuppressants) and diagnostic tools (such as assay kits, reagents, and laboratory instruments) used to identify and manage over 80 chronic, immune-mediated conditions where the immune system attacks the body's own tissues.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Autoimmune Disease Diagnostics and Drugs Market in the period 2025-30:

• The increasing prevalence of autoimmune disorders, currently affecting 5-9% of the global population, is the primary driver for market expansion.
• A significant shift from broad-spectrum immunosuppression toward targeted therapies, including novel monoclonal antibodies and small molecule inhibitors, is improving clinical outcomes.
• The rising impact of biosimilars following patent expiries of major biologics like Humira is increasing competition and treatment accessibility in emerging markets.
• Integration of Artificial Intelligence (AI) and machine learning in diagnostic platforms is enhancing pattern recognition and reducing turnaround times for complex tests.
• The expansion of personalized medicine is driving the demand for specific biomarkers to tailor therapeutic interventions to individual patient profiles.
• Adoption of multiplex platforms in clinical laboratories is allowing for the simultaneous processing of multiple autoantibody targets per sample, increasing efficiency.
• The development of Point-of-Care Testing (POCT) is gaining traction, enabling faster diagnosis and monitoring in decentralized clinical settings.

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments: